The bill requires the Bureau of Industry and Security (BIS) — through the Under Secretary for Industry and Security — to place the Ministry of Public Security’s Institute of Forensic Science of China on the Export Administration Regulations’ entity list within 60 days, and it specifies two institutional aliases. Inclusion triggers U.S. export-control restrictions on exports, reexports, and transfers of U.S.-origin items to that institute.
The President may waive the requirement if, within the same 60-day window, he certifies in writing to two congressional committees that the institute is not acting contrary to U.S. foreign policy and is not implicated in abuses against Muslim minority groups in Xinjiang. The bill is narrowly targeted but would create immediate compliance obligations for U.S. suppliers of forensic and related technology and could complicate transnational forensic cooperation and data-sharing with Chinese authorities.
At a Glance
What It Does
The bill orders BIS to add a named Chinese forensic institute and two aliases to the Entity List within 60 days of enactment, a step that brings EAR licensing requirements to exports, reexports, and transfers of U.S.-origin items to that entity. It also creates a single waiver path: the President, via the Secretary of Commerce, can waive the listing if he timely certifies to two congressional committees that the institute is not implicated in specific human-rights abuses.
Who It Affects
U.S. manufacturers and exporters of forensic equipment, DNA sequencing and analysis tools, biometric systems, forensic software, lab reagents, and related services will face new licensing reviews. Academic and law-enforcement partners that share tools, training, or data with the institute will need to recheck agreements and export compliance. BIS and export-control compliance teams will carry the operational workload of implementing the listing.
Why It Matters
Entity List placement is a practical lever: it can block or slow shipments of dual-use and commercial technologies used for surveillance and forensic identification, and it signals a targeted human-rights enforcement approach using export controls. For compliance officers and vendors of forensic and biometric tech, this bill proposes a near-term operational change that can alter contracts, sales, and collaboration with Chinese forensic institutions.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill is surgical in its scope. It names the Ministry of Public Security’s Institute of Forensic Science of China as the subject of an Entity List designation and lists two alternate names to prevent circumvention.
That naming forces BIS to revise the Entity List in the Export Administration Regulations (EAR) so that exports, reexports, and transfers of U.S.-origin items to the institute are subject to EAR license requirements.
Placing an entity on the Entity List does not automatically ban all shipments, but it brings those transactions into BIS’s licensing process; BIS will publish the listing and update regulatory guidance and licensing procedures. For many exporters of laboratory equipment, digital forensics tools, biometrics software, and sensitive reagents, the practical effect will be a heightened review process and, in many cases, additional documentation and end-use scrutiny.
Exporters that rely on third‑party reshippers or foreign-made components must map reexport and deemed‑export risks under the EAR.The bill also builds in a narrow escape hatch: the President can waive the placement if he certifies to the House Committee on Energy and Commerce and the Senate Committee on Commerce, Science, and Transportation within the 60-day period that the institute is not engaged in activities contrary to U.S. foreign policy and not implicated in abuses in Xinjiang. That certification is binary in the statute but open-ended in evidentiary terms — it focuses political and interagency judgment on whether to treat the institute as implicated.
If the President issues the waiver, BIS would not proceed with the listing mandated by the statute.Operationally, the change would land on export-control compliance teams fast. Companies will need to update internal screening lists, pause or reroute shipments pending license decisions, and expect BIS to request end-use or end-user statements.
For law-enforcement and academic collaborators, the listing raises questions about existing memoranda of understanding, mutual‑assistance relationships, and whether forensic cooperation can continue without new approvals. The bill ties export-control policy directly to a human‑rights determination about an identifiable institution, folding rights concerns into trade controls rather than, for example, visa or financial‑sanctions instruments.
The Five Things You Need to Know
The bill requires BIS’s Under Secretary for Industry and Security to add the Ministry of Public Security’s Institute of Forensic Science of China to the EAR Entity List within 60 days of enactment.
The statute names two aliases for the institute: the Forensic Identification Center of the Ministry of Public Security of the People’s Republic of China, and the Material Identification Center of the Ministry of Public Security of the People’s Republic of China.
The President may waive the listing if, within 60 days of enactment, he certifies to the House Committee on Energy and Commerce and the Senate Committee on Commerce, Science, and Transportation that the institute is not implicated in Xinjiang‑related abuses or acting contrary to U.S. foreign policy.
The waiver must be transmitted via the Secretary of Commerce (the President acting through the Secretary), creating a formal interagency channel for the certification.
The bill defines 'entity list' by cross‑reference to Supplement No. 4 to part 744 of the EAR, so the listing will be implemented through the existing EAR regulatory framework.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title: Confronting CCP Human Rights Abusers Act
This is the bill’s caption and signals congressional intent. While the short title has no operative effect on implementation, it frames the exercise as an export‑control response to human‑rights concerns and helps interpret the statutory text in administrative and congressional communications.
Mandatory inclusion of the Institute on the Entity List
Subsection (a) gives BIS a mandatory instruction: the Under Secretary must place the named institute (and the two specified aliases) on the Entity List no later than 60 days after enactment. Practically, BIS will publish a Federal Register notice and amend Supplement No. 4 to part 744 of the EAR. That administrative action imports EAR licensing obligations for shipments and transfers to the listed entity and triggers exporters’ screening obligations.
Presidential waiver and congressional certification requirement
Subsection (b) creates a single statutory exception: the President may prevent the listing by submitting a certification — transmitted via the Secretary of Commerce — to two specific congressional committees within the same 60‑day window. The certification must state that the institute is neither contrary to U.S. foreign policy nor implicated in Xinjiang‑related human‑rights abuses. This places political judgment and evidentiary assessment at the center of the implementation decision and requires interagency coordination to produce the certification on a tight timeline.
Integration with the Export Administration Regulations
Subsection (c) ties the statutory instruction directly into the existing EAR architecture by defining 'entity list' as the BIS list in Supplement No. 4 to part 744. That means BIS will use its established licensing, debarment, and reexport rules to operationalize the listing. Exporters must therefore evaluate both direct exports and reexports (including third‑country transfers and deemed exports) under the EAR’s existing controls.
This bill is one of many.
Codify tracks hundreds of bills on Foreign Affairs across all five countries.
Explore Foreign Affairs in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Human‑rights advocates and Uyghur organizations — gain a concrete U.S. tool to pressure specific institutions allegedly linked to abuses, and a public signal tying export controls to accountability.
- Policymakers and congressional staff focused on targeted accountability — obtain a narrowly tailored statutory mechanism to link technology flows to human‑rights enforcement without broad trade measures.
- Non‑U.S. suppliers and third‑country vendors of similar forensic equipment — may capture market share if U.S. suppliers face tighter restrictions, since U.S. origin items will face new licensing barriers.
- Export‑control compliance professionals — receive a clear statutory trigger and a defined target, allowing them to update screening lists and compliance processes rather than interpret more ambiguous policy guidance.
Who Bears the Cost
- U.S. manufacturers and exporters of forensic, biometric, and digital‑forensics equipment — face new license requirements, potential business loss, and the administrative costs of EAR compliance and end‑use checks.
- Academic and law‑enforcement collaborators (U.S. labs, universities, training programs) — may need to suspend or modify joint projects, data‑sharing arrangements, and training with the named institute pending license approvals.
- Bureau of Industry and Security and Commerce Department staff — absorb the immediate operational burden of drafting the listing, processing additional license applications, and conducting end‑use checks on short notice.
- Companies and intermediaries that reship or integrate components (global supply‑chain partners) — must map reexport and deemed‑export exposure, potentially redesigning logistics and documentation flows.
- International law‑enforcement cooperation — forensic mutual‑assistance or criminal investigations involving Chinese authorities could become more complicated if key forensic capabilities are restricted.
Key Issues
The Core Tension
The central dilemma is whether to use export controls to deny technology that enables alleged human‑rights abuses while accepting that those same controls can impede legitimate forensic cooperation and disrupt commercial supply chains; the bill favors targeted restriction, but the narrower the target, the easier it is for actors to route around the restriction or for enforcement to become resource‑intensive.
The bill creates a focused, administrable outcome but raises practical ambiguities. First, Entity List placement will not be a bright‑line ban; BIS retains licensing discretion and the EAR’s scope determines what is controlled.
Companies will need to make granular judgments about whether specific items — from mass‑market lab consumables to high‑end DNA sequencers or software — require licenses, a process that generates both compliance costs and legal risk. Second, the statute leaves the evidentiary standard for the presidential certification undefined.
What qualifies as "implicated in or contributing to" human‑rights abuses is a fact‑intensive judgment that will depend on interagency intelligence and diplomatic inputs; that ambiguity can produce either overcaution (broad denials) or under‑enforcement.
There are also operational trade‑offs. The bill penalizes a single institutional actor rather than an entire sector, which reduces collateral economic impact but may be easy to evade through subcontracting or rebranding.
Tight export controls can push buyers to substitute non‑U.S. vendors, reducing leverage over Chinese practices while also exposing U.S. firms to lost markets. Finally, the provision could complicate legitimate forensic collaboration needed for transnational criminal investigations, raising questions about whether export controls are the right instrument for restricting technologies that also serve public‑safety purposes.
Administratively, BIS will need to calibrate license review policy and compliance guidance quickly to limit uncertainty for exporters and downstream users.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.